Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Etxeberria I, Bolanos E, Teijeira A, Garasa S, et al. Proc Natl Acad Sci U S A 2021;118.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Etxeberria I, Bolanos E, Teijeira A, Garasa S, et al. Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Proc Natl Acad Sci U S A 2021;118.
PMID: 34172583